Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its structure supports the construction of peptidomimetics, where the cyclohexane ring provides conformational restraint, enhancing selectivity and metabolic stability. Commonly employed in solid-phase and solution-phase peptide synthesis, it serves to introduce a protected amino acid functionality with defined stereochemistry. The benzyl carbamate (Cbz) protecting group allows for selective deprotection under mild conditions, enabling stepwise assembly of complex molecules. Valuable in medicinal chemistry for optimizing drug candidates targeting enzymes and receptors where stereochemistry and ring constraints influence activity.